These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 503288)
1. Restoration of the prolactin response to sulpiride by metergoline administration in hyperprolactinemic patients. Ferrari C; Travaglini P; Caldara R; Moriondo P; Mattei A; Crosignani PG; Faglia G Neuroendocrinology; 1979; 29(5):338-45. PubMed ID: 503288 [No Abstract] [Full Text] [Related]
2. Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia. Falsetti L; Roggia A; Loda G; Turla R; Scagliola T; Schimberni M; Pontiroli AE Horm Metab Res; 1983 Aug; 15(8):380-4. PubMed ID: 6618428 [TBL] [Abstract][Full Text] [Related]
3. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature. Farrari C; Telloli P; Rampini P; Caldara R Gynecol Obstet Invest; 1980; 11(6):317-26. PubMed ID: 6785158 [TBL] [Abstract][Full Text] [Related]
4. Serum prolactin and ovarian function after discontinuation of drug treatment for hyperprolactinaemia: a study with bromocriptine and metergoline. Mattei AM; Ferrari C; Ragni G; Benco R; Picciotti MC; Rampini P; Caldara R; Crosignani PG Br J Obstet Gynaecol; 1984 Mar; 91(3):244-50. PubMed ID: 6704349 [TBL] [Abstract][Full Text] [Related]
5. Treatment of hyperprolactinemic amenorrhea with Metergoline. Bohnet HG; Kato K; Wolf AS Obstet Gynecol; 1986 Feb; 67(2):249-52. PubMed ID: 3945435 [TBL] [Abstract][Full Text] [Related]
6. Restoration of cyclic ovarian function by metergoline treatment in a patient with a prolactin-secreting pituitary microadenoma. Ferrari C; Caldara R; Telloli P; Rampini P; Bertazzoni A Fertil Steril; 1978 Aug; 30(2):237-9. PubMed ID: 680200 [TBL] [Abstract][Full Text] [Related]
7. Treatment of hyperprolactinemic states with different drugs: a study with bromocriptine, metergoline, and lisuride. Crosignani PG; Ferrari C; Liuzzi A; Benco R; Mattei A; Rampini P; Dellabonzana D; Scarduelli C; Spelta B Fertil Steril; 1982 Jan; 37(1):61-7. PubMed ID: 7199483 [TBL] [Abstract][Full Text] [Related]
8. [Methergoline therapy of hyperprolactinemic amenorrhea. Observations on 22 cases]. Rossetti MG; Belforte L; Bruno M; Lanza MG; Peris C; Vaudano G; Campagnoli C Minerva Ginecol; 1981 Jun; 33(6):586-9. PubMed ID: 7279283 [No Abstract] [Full Text] [Related]
9. Metergoline as an alternative to bromocriptine in amenorrhoea. Hicks BH; Finer N; Herbert LC Acta Endocrinol (Copenh); 1984 Dec; 107(4):439-44. PubMed ID: 6440388 [TBL] [Abstract][Full Text] [Related]
10. Metergoline treatment of hyperprolactinemic states. Crosignani PG; Ferrari C; Mattei A; Fadini R; Meschia M; Caldara R; Rampini P; Telloli P; Reschini E Fertil Steril; 1979 Sep; 32(3):280-5. PubMed ID: 488408 [No Abstract] [Full Text] [Related]
12. [Results of different types of treatment in prolactin adenoma]. Leal Cerro A; García-Luna PP; Astorga Jiménez R; Acosta Delgado D; Santos Español C; Villamil F Med Clin (Barc); 1985 Dec; 85(20):823-6. PubMed ID: 4087967 [No Abstract] [Full Text] [Related]
13. [Clinical results in the treatment with metergoline in 80 hyperprolactinemic patients]. Falsetti L; Scagliola P; Turla R; Voltolini AM Minerva Med; 1981 Sep; 72(35):2351-4. PubMed ID: 7279256 [TBL] [Abstract][Full Text] [Related]
14. [Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline]. Mussa A; Sandrucci S; Dogliotti L Minerva Med; 1979 Nov; 70(51):3493-8. PubMed ID: 522987 [TBL] [Abstract][Full Text] [Related]
15. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine. Hirvonen E; Ranta T; Seppäla M J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453 [TBL] [Abstract][Full Text] [Related]
16. Effect of bromocriptine and metergoline in the treatment of hyperprolactinaemic states. Ambrosi B; Travaglini P; Moriondo P; Nissim M; Nava C; Bochicchio D; Faglia G Acta Endocrinol (Copenh); 1982 May; 100(1):10-7. PubMed ID: 6810607 [TBL] [Abstract][Full Text] [Related]
17. [Clinical experiences with the prolactin-inhibiting serotonin antagonist metergoline]. Schneider WH; Huber H; Spona J Wien Klin Wochenschr; 1983 Jun; 95(13):452-5. PubMed ID: 6636776 [TBL] [Abstract][Full Text] [Related]
18. Stimulating action of sulpiride and pimozide on prolactin release. Effect on bromocriptine, L-dopa and metergoline administration. Delitala G Acta Endocrinol (Copenh); 1977 Oct; 86(2):251-6. PubMed ID: 578618 [TBL] [Abstract][Full Text] [Related]
19. [Hyperprolactinemic amenorrhea and sterility treated with bromocriptine]. Polishuk WZ; Yarkoni S; Ben-David M; Spitz J Harefuah; 1975 Dec; 89(11):500-3. PubMed ID: 1205386 [No Abstract] [Full Text] [Related]
20. Comparison of dopamine agonists in the treatment of hyperprolactinemic syndromes: a multicenter study. Blackwell RE; Bradley EL; Kline LB; Duvall ER; Vitek JJ; DeVane GW; Chang RJ Fertil Steril; 1983 Jun; 39(6):744-8. PubMed ID: 6343127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]